Confirmation of Diet as a Treatment for Gulf War Illness
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- American University
- Study ID
- NCT05675878
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Gulf War Illness
- Gulf War Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Dietary Intervention — BEHAVIORALThis is a whole food, nutrient-dense diet that aims to remove exposure to specific food additives thought to have negative neurological effects, while also optimizing micronutrient intake.
Study Details
This clinical trial aims to confirm previous findings from a smaller study which demonstrated significant improvements in all symptoms among veterans with Gulf War Illness after one month on the dietary intervention. The main objectives of this study are: 1) to confirm previous findings of treatment response to the diet in a larger and more diverse group; 2) to examine how changes in the nervous system may be the reason for improvement; and 3) to identify markers which change in the blood after one month on the diet. Participants will have baseline measures collected and then will be randomized into the intervention or wait-listed control group, which they will follow for one month before being reassessed.
Key Dates
- Start date
- Mar 1, 2023
- Status verified
- Jul 2024
- Primary completion
- Aug 31, 2025
- Completion
- Dec 30, 2025
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Dietary Intervention GroupSubjects will undergo a 2-hour in-depth training via Zoom on how to follow the diet and will receive a binder with helpful information. They will be give the weekend to prepare and then will start the diet the following Monday, and will continue following it for 4 weeks before being reassessed in the lab.
- No Intervention: Waitlisted Control GroupThe waitlisted control group will follow their usual diet for one month and then will be reassessed (as a comparator group) before being trained on the dietary intervention which they will then follow for the next month.
Primary Outcome Measure
Total Symptom Score [ Time Frame: 1-month ]
Central Contacts
- Houra Taheri, PhD202- 885-3810
- Kathleen F Holton, PhD, MPH202-885-3797
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| American University | Washington D.C. | District of Columbia | 20016 | Houra Taheri, PhD Kathleen F Holton, PhD, MPH (PRINCIPAL_INVESTIGATOR) |
| Nova Southeastern University | Fort Lauderdale | Florida | 33314 | Amanpreet Cheema, PhD (PRINCIPAL_INVESTIGATOR) |
| Boston University | Boston | Massachusetts | 02118 | Kimberly Sullivan, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Washington D.C., DC
Related Studies
- Study of Bacopa in Gulf War Illness PatientsPHASE2 · Recruiting · Nova Southeastern University · Davie, Florida
- GWICTIC: NAC Mechanistic Study in Gulf War VeteransEARLY_PHASE1 · Recruiting · Nova Southeastern University · Palo Alto, California
- Nicotinamide Riboside Clinical Trial for GWIRecruiting · Roskamp Institute Inc. · Fort Lauderdale, Florida
- Ca-Mg Butyrate in GWIPHASE2 · Recruiting · VA Office of Research and Development · Long Beach, California